Transplantation, AutologousHematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousAntineoplastic Combined Chemotherapy ProtocolsTransplantation ConditioningMultiple MyelomaCombined Modality TherapyBone Marrow TransplantationStem CellsMelphalanTreatment OutcomeCyclophosphamideHematopoietic Stem Cell MobilizationBone MarrowEtoposideAntigens, CD34Bone Marrow CellsGraft SurvivalRemission InductionHematopoietic Stem CellsSalvage TherapyDisease-Free SurvivalHematologic NeoplasmsGraft vs Host DiseaseLymphoma, Non-HodgkinGranulocyte Colony-Stimulating FactorHodgkin DiseaseRecurrenceMyeloablative AgonistsBone Marrow PurgingCytarabineCarmustineSurvival RateSurvival AnalysisWhole-Body IrradiationThiotepaBusulfanRetrospective StudiesVincristineDoxorubicinPrognosisTime FactorsAmyloidosisAntineoplastic AgentsFollow-Up StudiesDexamethasoneAntineoplastic Agents, AlkylatingMesenchymal Stem Cell TransplantationTissue DonorsLeukapheresisLymphoma, Mantle-CellBoronic AcidsIfosfamideEmbryonic Stem CellsBone and BonesPyrazinesLeukemia, Myeloid, AcuteAntibodies, Monoclonal, Murine-DerivedLymphomaLymphoma, FollicularAdult Stem CellsTransplantation ChimeraChemotherapy, AdjuvantCell DifferentiationHematopoiesisLymphoma, T-Cell, PeripheralThalidomideImmunosuppressive AgentsKidney TransplantationAutograftsPrednisoneHistocompatibility TestingInduction ChemotherapyTransplantationBlood Component RemovalCord Blood Stem Cell TransplantationProspective StudiesLiver TransplantationFatal OutcomeNeoplasm, ResidualLymphoma, Large B-Cell, DiffuseLeukemiaNeoplasmsCell TransplantationMyelodysplastic SyndromesCells, CulturedCytomegalovirus InfectionsBlood Transfusion, AutologousHistocompatibilityPluripotent Stem CellsPodophyllotoxinMesenchymal Stromal CellsCisplatinCarboplatinFlow CytometryT-LymphocytesStem Cell NicheMaintenance Chemotherapy